292 related articles for article (PubMed ID: 26593333)
21. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
22. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
[TBL] [Abstract][Full Text] [Related]
23. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
[TBL] [Abstract][Full Text] [Related]
25. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
[TBL] [Abstract][Full Text] [Related]
26. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
Hauser RG; Hayes DL
Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
[TBL] [Abstract][Full Text] [Related]
27. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
[TBL] [Abstract][Full Text] [Related]
28. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?
Glikson M; Suleiman M; Luria DM; Martin ML; Hodge DO; Shen WK; Bradley DJ; Munger TM; Rea RF; Hayes DL; Hammill SC; Friedman PA
Heart Rhythm; 2009 Jan; 6(1):65-8. PubMed ID: 19121802
[TBL] [Abstract][Full Text] [Related]
29. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
[TBL] [Abstract][Full Text] [Related]
30. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
31. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
[TBL] [Abstract][Full Text] [Related]
32. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.
Brunner MP; Cronin EM; Duarte VE; Yu C; Tarakji KG; Martin DO; Callahan T; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
Heart Rhythm; 2014 May; 11(5):799-805. PubMed ID: 24444444
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
34. Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Thøgersen AM; Hjortshøj SP
Heart Rhythm; 2014 Dec; 11(12):2141-7. PubMed ID: 25008285
[TBL] [Abstract][Full Text] [Related]
35. A randomized prospective study of single coil versus dual coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy.
Rinaldi CA; Simon RD; Geelen P; Reek S; Baszko A; Kuehl M; Gill JS
Pacing Clin Electrophysiol; 2003 Aug; 26(8):1684-90. PubMed ID: 12877701
[TBL] [Abstract][Full Text] [Related]
36. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
37. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
38. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
[TBL] [Abstract][Full Text] [Related]
39. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
